You searched for dna - Page 34 of 40

News and Trends 30 Mar 2016

German Biotech targets China for Lung Cancer Liquid Biopsies

…in early stage and manageable. This is exactly what Epigenomics, one of our favorite Biotechs in Berlin, is doing. Based on their expertise in DNA methylation, one of the most…

March 30, 2016 - 3 minutesmins - By Denise Neves Gameiro

More News! 26 Oct 2022

Study shows ability to develop and apply targeted treatment in head and neck cancers

…cellular characteristics of the tumors using DNA sequencing of 127 tissue samples from affected patients. They used artificial intelligence (AI) and positron emission tomography (PET) as an imaging method. The…

October 26, 2022 - 3 minutesmins - By Liza Laws

crispr charpentier ers genomics bayer blsc

News and Trends 18 May 2016

Bayer claims CRISPR Patents for Gene-Editing Agreements

…technology combination and know-how amplification. Fig. 1: Cas9 DNA-splicer programmed by RNA strands, in illustrations from Charpentier’s ground-breaking paper in CRISPR. BLSC has now struck a deal with an important…

May 18, 2016 - 2 minutesmins - By Denise Neves Gameiro

News and Trends 9 Feb 2017

Alma Bio Therapeutics is Aiming to Revolutionize the Treatment of IBD

…working relationship with a manufacturer, Delphi Genetics, to generate our DNA plasmid based product. Your technology aims to reinstate Immune Tolerance. Why did you choose IBD as an indication? IBD…

February 9, 2017 - 6 minutesmins - By External Contributor

News and Trends 25 May 2017

Resilient Tumor Cells Drive Breast Cancer Relapse in Mice

…turn that steer oxidative DNA damage, which they believe, to cause tumor recurrence. The results from mouse models were consistent with samples from patients. Using chemical inhibitors, the researchers then…

May 25, 2017 - 3 minutesmins - By External Contributor

In Depth 22 Jul 2022

The coming of age story of RNAi technology

…there were times when it seemed RNAi therapies might be consigned to the dustbin of ideas that failed. As every biology student learns early on, DNA makes RNA and RNA…

July 22, 2022 - 7 minutesmins - By Farhan Mitha

News and Trends 15 Aug 2019

Swiss Scientists Upgrade CRISPR to Edit Many Genes at Once

…genome editing technique, CRISPR-Cas9, uses the DNA-cutting enzyme Cas9 and an RNA molecule that guides Cas9 where to cut on the genome. Instead of Cas9, this latest study published in…

August 15, 2019 - 3 minutesmins - By Jonathan Smith

News and Trends 2 Jul 2020

Freeline Closes €106M Series C to Progress Hemophilia Gene Therapy

…and hemophilia A. The company will also expand its gene therapy manufacturing capacity. The company’s technology consists of delivering therapeutic DNA into patients via a viral vector. The technology has…

July 2, 2020 - 3 minutesmins - By Helen Albert

Opinion 12 Dec 2022

Artificial intelligence: a new era in rare genetic disease diagnosis

…data you feed it. Limitations arise in the form of non-coding pathogenic variants, ancestry-specific bias in genomic datasets and patient data protection issues. Non-coding variants are regions of the DNA sequence…

December 12, 2022 - 6 minutesmins - By External Contributor

News and Trends 28 Jul 2022

Mission Bio launches new cancer assay

…sensitivity and specificity of commercial MRD tests used today both in research and to predict cancer recurrence in patients, leveraging the Tapestri Platform’s ability to measure DNA and surface protein…

July 28, 2022 - 3 minutesmins - By Jim Cornall

Centogene Rare Disease Diagnostics Series A

News and Trends 13 Jun 2017

German Biotech Raises €25M to Fuel Diagnostics of Rare Diseases

…as Shire, and recently entered a collaboration with US-based FDNA to support FDNA’s comprehensive database that combines phenotypic and genomic information associated with over 8,000 rare diseases and genetic disorders….

June 13, 2017 - 2 minutesmins - By Melanie De Almeida

elypta renal cell carcinoma kidney blood cancer

News and Trends 4 Feb 2019

Swedish Biotech Receives EU Grant for High-Accuracy Kidney Cancer Test

…renal cell carcinoma that we know of,” Karl Bergman, CEO of Elypta, told me. While most blood and urine cancer tests detect genetic material such as DNA, Elypta measures the…

February 4, 2019 - 2 minutesmins - By Jonathan Smith

Knowledge hub

Categories

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

These 7 biotechs are shaping the next generation of endometriosis care

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: dna

German Biotech targets China for Lung Cancer Liquid Biopsies

Study shows ability to develop and apply targeted treatment in head and neck cancers

Bayer claims CRISPR Patents for Gene-Editing Agreements

Alma Bio Therapeutics is Aiming to Revolutionize the Treatment of IBD

Resilient Tumor Cells Drive Breast Cancer Relapse in Mice

The coming of age story of RNAi technology

Swiss Scientists Upgrade CRISPR to Edit Many Genes at Once

Freeline Closes €106M Series C to Progress Hemophilia Gene Therapy

Artificial intelligence: a new era in rare genetic disease diagnosis

Mission Bio launches new cancer assay

German Biotech Raises €25M to Fuel Diagnostics of Rare Diseases

Swedish Biotech Receives EU Grant for High-Accuracy Kidney Cancer Test

Subscribe to our newsletter to get the latest biotech news!

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!